A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Glioblastoma|Melanoma Stage IV|Breast Cancer|Prostate Cancer|Glioblastoma Multiforme|GBM|Brain Cancer|Metastatic Breast Cancer|Metastatic Melanoma|Metastatic Prostate Cancer|Melanoma Recurrent|Prostate Cancer Metastatic|Recurrent Glioblastoma|Newly Diagnosed Glioblastoma
Interventions: DRUG: ST101|DRUG: Temozolomide|RADIATION: Radiation
Sponsor: Sapience Therapeutics